Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
Breier
G
G
Max-Planck-Institut für physiologische und klinische Forschung, Bad Nauheim.
Heidenreich
R
R
Gaumann
A
A
Groot
M
M
Licht
A
A
Nicolaus
A
A
Schmitz
J
J
Reichmann
E
E
Plate
K H
KH
Vajkoczy
P
P
D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D000818:Animals; D016228:Endothelial Growth Factors / Q000502:physiology; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000502:physiology; D008222:Lymphokines / Q000502:physiology; D008325:Mammary Neoplasms, Experimental / Q000098:blood supply / Q000503:physiopathology; D051379:Mice; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000517:prevention & control*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000187:drug effects / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D040262:Receptors, Vascular Endothelial Growth Factor